The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Bangladesh · Delayed Price · Currency is BDT

297.20

-0.70 (-0.23%)

At close: Nov 4, 2026

Market Cap	9.29B +1.3%
Revenue (ttm)	13.90B +17.0%
Net Income	794.63M +25.5%
EPS	25.43 +25.5%
Shares Out	31.24M
PE Ratio	11.69
Forward PE	n/a
Dividend	7.70 (2.59%)
Ex-Dividend Date	Oct 27, 2026

Volume	1,250
Open	n/a
Previous Close	297.90
Day's Range	295.10 - 301.90
52-Week Range	285.00 - 371.00
Beta	0.20
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC, together with its subsidiaries, engages in the production and sale of pharmaceutical drugs in Bangladesh and internationally. The company offers its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension; and sterile ophthalmic products, creams, ointments, gels, eye drops, and sachet. It also provides products in various therapeutic ... [Read more]

Industry Pharmaceutical Preparations

Founded 1983

Employees 5,200

Stock Exchange Dhaka Stock Exchange

Ticker Symbol IBNSINA

Full Company Profile

Financial Performance

In fiscal year 2026, DSE:IBNSINA's revenue was 13.90 billion, an increase of 16.97% compared to the previous year's 11.88 billion. Earnings were 794.63 million, an increase of 25.50%.

Financial Statements